×
About 165,463 results

ALLMedicine™ Insulin Center

Research & Reviews  57,168 results

Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes
https://clinicaltrials.gov/ct2/show/NCT02960659

May 20th, 2022 - Type 2 Diabetes in youth is an emerging public health concern that disproportionately affects minority children. Among minority youth, African-Americans have the highest complication rates, yet the reasons underlying this health disparity are not ...

Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta 3-Adrenergic Receptor Agonists
https://clinicaltrials.gov/ct2/show/NCT03049462

May 20th, 2022 - Background issues and controversies More than ever before, there is a rise in the rates of obesity and diabetes. As opposed to white fat which stores excess calories, brown fat - also known as brown adipose tissue or BAT-consumes this energy to ge...

Caffeine Ingestion to Counter the Exercise-mediated Fall in Glycaemia in Type 1 Diabetes
https://clinicaltrials.gov/ct2/show/NCT04671043

May 20th, 2022 - Treatment of type 1 diabetes (T1D) involves lifelong use of exogenous insulin to manage blood glucose concentration. As with the rest of the population, people living with T1D are recommended to engage in regular exercise for a variety of health a...

The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)
https://clinicaltrials.gov/ct2/show/NCT01778569

May 20th, 2022 - Over the past two decades, inflammation has been identified as an important pathogenic process in cardiometabolic diseases (CMD) such atherosclerotic cardiovascular disease (CVD), dyslipidemia, insulin resistance, diabetes and obesity. However, me...

Effect of Preoperative Carbohydrate Loading in Femur Fracture
https://clinicaltrials.gov/ct2/show/NCT04838366

May 20th, 2022 - Femur fracture is one of the most common cause for hospital stay in the case of elder people. Besides these, the patients have the stress of surgery. According to existing practice, the patients are kept in fasting state from the midnight that mak...

see more →

Guidelines  37 results

Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Pro...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019936
Orphanet Journal of Rare Diseases; Mosbah H, Donadille B et. al.

Apr 21st, 2022 - Dunnigan syndrome, or Familial Partial Lipodystrophy type 2 (FPLD2; ORPHA 2348), is a rare autosomal dominant disorder due to pathogenic variants of the LMNA gene. The objective of the French National Diagnosis and Care Protocol (PNDS; Protocole N...

Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2
https://www.cell.com/cell-metabolism/fulltext/S1550-4131(21)00428-9?_returnURL=https://linkinghub.elsevier.com/retrieve/pii/S1550413121004289?showall=true
Cell Metabolism; Reiterer M, .

Sep 15th, 2021 - Individuals infected with SARS-CoV-2 who also display hyperglycemia suffer from longer hospital stays, higher risk of developing acute respiratory distress syndrome (ARDS), and increased mortality. Nevertheless, the pathophysiological mechanism of...

Glucose management for exercise using continuous glucose monitoring (CGM) and intermitt...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702152
Pediatric Diabetes; Moser O, Riddell MC et. al.

Oct 14th, 2020 - Physical exercise is an important component in the management of type 1 diabetes across the lifespan. Yet, acute exercise increases the risk of dysglycaemia, and the direction of glycaemic excursions depends, to some extent, on the intensity and d...

ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID...
https://doi.org/10.1111/pedi.13118
Pediatric Diabetes; Priyambada L, Wolfsdorf JI et. al.

Sep 17th, 2020 - The International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guideline 2018 for management of diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar state provide comprehensive guidance for management of DKA ...

Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020...
https://doi.org/10.7326/M20-2470
Annals of Internal Medicine; Doyle-Delgado K, Chamberlain JJ et. al.

Sep 1st, 2020 - The American Diabetes Association (ADA) updates the Standards of Medical Care in Diabetes annually to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis and managem...

see more →

Drugs  343 results see all →

Clinicaltrials.gov  3,563 results

Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)
https://clinicaltrials.gov/ct2/show/NCT03407079

May 20th, 2022 - Background: Consumption of non-nutritive sweeteners (NNS) has dramatically increased worldwide and is more prevalent in women than men. Similarly, obesity rates have continued to rise, most notably in minorities. Since NNS consumption has been lin...

Prospective Studies of the Natural History of Diabetes Mellitus and Its Complications in the Gila River Indian Community
https://clinicaltrials.gov/ct2/show/NCT00339482

May 20th, 2022 - This project is a continuation of an extensive longitudinal population-based epidemiological investigation of the etiology and determinants of type 2 diabetes (and its complications) and formerly arthritis. The original baseline observations were ...

Ketone Ester Effects on Biomarkers of Brain Metabolism and Cognitive Performance in Cognitively Intact Adults 55 Years Old or Older
https://clinicaltrials.gov/ct2/show/NCT04421014

May 20th, 2022 - Study Description: We hypothesize that supplementation with a ketone ester drink [Ketone Ester (KE)] compared to placebo, in cognitively intact adults >= 55 years old with Metabolic Syndrome (MetS), will (i) increase peripheral and brain ketone le...

Cross-Sectional and Longitudinal Studies of "Pre-Diabetes" in the Pima Indians
https://clinicaltrials.gov/ct2/show/NCT00340132

May 20th, 2022 - Insulin resistance and a defect in early insulin secretion are risk factors for the development of type 2 diabetes mellitus. A recent longitudinal analysis which tracked the development of diabetes demonstrated that both insulin action and early i...

Health Economic Analysis of Islet Cell Transplantation for the Stabilization of the Severe Forms of Type 1 Diabetes
https://clinicaltrials.gov/ct2/show/NCT02854696

May 20th, 2022 - The main goal is to perform a cost-utility analysis to compare islet cell transplantation versus best medical treatment (defined as Sensor augmented insulin pump therapy) for patients with brittle type1 diabetes.

see more →

News  5,030 results

Pancreatic Involvement in COVID-19: What Do We Know?
https://www.medscape.com/viewarticle/974291

May 19th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. MADRID — There is increasing evidence of the impact that SARS-CoV-2 infection has on patients with diabetes. It involves the relationship between ...

Does COVID-19 Raise the Risk for Diabetes?
https://www.medscape.com/viewarticle/972835

May 17th, 2022 - This transcript has been edited for clarity. Does having had a COVID-19 infection increase your risk for the development of diabetes subsequently? Some data say yes and other data say no. No matter what, it's obviously important to screen people f...

Fast Five Quiz: Type 2 Diabetes Incretin-Based Therapy
https://www.medscape.com/viewarticle/951449

May 16th, 2022 - Disease burden in patients with type 2 diabetes is largely driven by the associated long-term complications, making glycemic control an invaluable treatment goal. In 2005, the first incretin-based agent was introduced into the type 2 diabetes trea...

First Fatty Liver Guidelines for Endocrinology, Primary Care
https://www.medscape.com/viewarticle/973928

May 13th, 2022 - New clinical practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) are the first to be targeted specifically to primary care and endocrinology clinical settings. They include 34 evidence-based clinical pr...

Arkansas Sues Drugmakers, Pharmacy Benefit Managers Over Insulin Costs
https://www.medscape.com/viewarticle/973799

May 12th, 2022 - (Reuters) - Arkansas's attorney general on Wednesday accused drugmakers and pharmacy benefit managers of colluding to drive up the price of insulin drugs, the latest in a series of lawsuits to take aim at skyrocketing insulin costs. The lawsuit, f...

see more →

Patient Education  44 results see all →